Anaplastic thyroid cancer in young patients: A contemporary review

Mingsi Li, Mira Milas, Christian Nasr, Jennifer A. Brainard, Mumtaz J. Khan, Brian B. Burkey, Joseph Scharpf

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Little is known about prognostic factors and treatment outcomes in young patients with anaplastic thyroid cancer (ATC). The goal of this study is to define the clinical features of this subgroup. Material and methods: Patients age 55 or younger with either ATC or well-differentiated thyroid cancer (WDTC) with anaplastic changes were identified using electronic medical record at the Cleveland Clinic. The same number of patients older than 55 was randomly selected to serve as control. Progression-free survival (PFS), overall survival time (OST) and cause-specific mortality (CSM) were measured against age, tumor histology, extent of disease, and treatment modalities. Results: Twelve patients age 55 or younger were identified. The median age was 51 years. Four patients had WDTC with anaplastic components - mixed tumor group (MTG). Their median PFS, OST, and CSM at 24 months were 21.5 months, 51 months, and 25%, respectively. For the other 8 patients who had pure ATC, their median PFS, OST, and CSM were 3.5 months, 6 months, and 100%, respectively. Patients in the MTG had better survival compared to the pure ATC and control group in terms of PFS (p = 0.0047 and p = 0.0053), OST (p = 0.0028 and p = 0.0029) and the CSM at 24 months (p = 0.0339 and p = 0.0096). In the pure ATC group, patients with positive cervical lymph node and distant metastases had similar overall survival outcomes (6 vs. 8 months, p = 0.4995). Conclusion: Prognostic factors favoring survival in young patients with ATC include ATC arising within WDTC. Once full anaplastic transformation occurs, age was not a significant factor in survival.

Original languageEnglish (US)
Pages (from-to)636-640
Number of pages5
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume34
Issue number6
DOIs
StatePublished - Nov 1 2013
Externally publishedYes

Fingerprint

Survival
Disease-Free Survival
Mortality
Anaplastic Thyroid Carcinoma
Neoplasms
Electronic Health Records
Thyroid Neoplasms
Histology
Lymph Nodes
Neoplasm Metastasis
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Anaplastic thyroid cancer in young patients : A contemporary review. / Li, Mingsi; Milas, Mira; Nasr, Christian; Brainard, Jennifer A.; Khan, Mumtaz J.; Burkey, Brian B.; Scharpf, Joseph.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 34, No. 6, 01.11.2013, p. 636-640.

Research output: Contribution to journalArticle

Li, Mingsi ; Milas, Mira ; Nasr, Christian ; Brainard, Jennifer A. ; Khan, Mumtaz J. ; Burkey, Brian B. ; Scharpf, Joseph. / Anaplastic thyroid cancer in young patients : A contemporary review. In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 2013 ; Vol. 34, No. 6. pp. 636-640.
@article{313ea332c5554d8b8f13c783791a0cac,
title = "Anaplastic thyroid cancer in young patients: A contemporary review",
abstract = "Purpose: Little is known about prognostic factors and treatment outcomes in young patients with anaplastic thyroid cancer (ATC). The goal of this study is to define the clinical features of this subgroup. Material and methods: Patients age 55 or younger with either ATC or well-differentiated thyroid cancer (WDTC) with anaplastic changes were identified using electronic medical record at the Cleveland Clinic. The same number of patients older than 55 was randomly selected to serve as control. Progression-free survival (PFS), overall survival time (OST) and cause-specific mortality (CSM) were measured against age, tumor histology, extent of disease, and treatment modalities. Results: Twelve patients age 55 or younger were identified. The median age was 51 years. Four patients had WDTC with anaplastic components - mixed tumor group (MTG). Their median PFS, OST, and CSM at 24 months were 21.5 months, 51 months, and 25{\%}, respectively. For the other 8 patients who had pure ATC, their median PFS, OST, and CSM were 3.5 months, 6 months, and 100{\%}, respectively. Patients in the MTG had better survival compared to the pure ATC and control group in terms of PFS (p = 0.0047 and p = 0.0053), OST (p = 0.0028 and p = 0.0029) and the CSM at 24 months (p = 0.0339 and p = 0.0096). In the pure ATC group, patients with positive cervical lymph node and distant metastases had similar overall survival outcomes (6 vs. 8 months, p = 0.4995). Conclusion: Prognostic factors favoring survival in young patients with ATC include ATC arising within WDTC. Once full anaplastic transformation occurs, age was not a significant factor in survival.",
author = "Mingsi Li and Mira Milas and Christian Nasr and Brainard, {Jennifer A.} and Khan, {Mumtaz J.} and Burkey, {Brian B.} and Joseph Scharpf",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.amjoto.2013.07.008",
language = "English (US)",
volume = "34",
pages = "636--640",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Anaplastic thyroid cancer in young patients

T2 - A contemporary review

AU - Li, Mingsi

AU - Milas, Mira

AU - Nasr, Christian

AU - Brainard, Jennifer A.

AU - Khan, Mumtaz J.

AU - Burkey, Brian B.

AU - Scharpf, Joseph

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Purpose: Little is known about prognostic factors and treatment outcomes in young patients with anaplastic thyroid cancer (ATC). The goal of this study is to define the clinical features of this subgroup. Material and methods: Patients age 55 or younger with either ATC or well-differentiated thyroid cancer (WDTC) with anaplastic changes were identified using electronic medical record at the Cleveland Clinic. The same number of patients older than 55 was randomly selected to serve as control. Progression-free survival (PFS), overall survival time (OST) and cause-specific mortality (CSM) were measured against age, tumor histology, extent of disease, and treatment modalities. Results: Twelve patients age 55 or younger were identified. The median age was 51 years. Four patients had WDTC with anaplastic components - mixed tumor group (MTG). Their median PFS, OST, and CSM at 24 months were 21.5 months, 51 months, and 25%, respectively. For the other 8 patients who had pure ATC, their median PFS, OST, and CSM were 3.5 months, 6 months, and 100%, respectively. Patients in the MTG had better survival compared to the pure ATC and control group in terms of PFS (p = 0.0047 and p = 0.0053), OST (p = 0.0028 and p = 0.0029) and the CSM at 24 months (p = 0.0339 and p = 0.0096). In the pure ATC group, patients with positive cervical lymph node and distant metastases had similar overall survival outcomes (6 vs. 8 months, p = 0.4995). Conclusion: Prognostic factors favoring survival in young patients with ATC include ATC arising within WDTC. Once full anaplastic transformation occurs, age was not a significant factor in survival.

AB - Purpose: Little is known about prognostic factors and treatment outcomes in young patients with anaplastic thyroid cancer (ATC). The goal of this study is to define the clinical features of this subgroup. Material and methods: Patients age 55 or younger with either ATC or well-differentiated thyroid cancer (WDTC) with anaplastic changes were identified using electronic medical record at the Cleveland Clinic. The same number of patients older than 55 was randomly selected to serve as control. Progression-free survival (PFS), overall survival time (OST) and cause-specific mortality (CSM) were measured against age, tumor histology, extent of disease, and treatment modalities. Results: Twelve patients age 55 or younger were identified. The median age was 51 years. Four patients had WDTC with anaplastic components - mixed tumor group (MTG). Their median PFS, OST, and CSM at 24 months were 21.5 months, 51 months, and 25%, respectively. For the other 8 patients who had pure ATC, their median PFS, OST, and CSM were 3.5 months, 6 months, and 100%, respectively. Patients in the MTG had better survival compared to the pure ATC and control group in terms of PFS (p = 0.0047 and p = 0.0053), OST (p = 0.0028 and p = 0.0029) and the CSM at 24 months (p = 0.0339 and p = 0.0096). In the pure ATC group, patients with positive cervical lymph node and distant metastases had similar overall survival outcomes (6 vs. 8 months, p = 0.4995). Conclusion: Prognostic factors favoring survival in young patients with ATC include ATC arising within WDTC. Once full anaplastic transformation occurs, age was not a significant factor in survival.

UR - http://www.scopus.com/inward/record.url?scp=84887105266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887105266&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2013.07.008

DO - 10.1016/j.amjoto.2013.07.008

M3 - Article

C2 - 23993450

AN - SCOPUS:84887105266

VL - 34

SP - 636

EP - 640

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

IS - 6

ER -